Overview and Scope
The CyberKnife System is a non-invasive treatment for malignant and non-cancerous tumors and other disorders where radiation therapy is recommended. This allows for smaller treatment margins around the tumor, minimizing the amount of healthy tissue exposed to a high radiation dose.
Sizing and Forecast
The cyberknife market size has grown rapidly in recent years. It will grow from $0.55 billion in 2023 to $0.64 billion in 2024 at a compound annual growth rate (CAGR) of 17.7%. The growth in the historic period can be attributed to rising cancer incidence, growing aging population, demand for precision medicine, patient preference for non-invasive procedures, advancements in radiotherapy.
The cyberknife market size is expected to see rapid growth in the next few years. It will grow to $1.16 billion in 2028 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to increasing cancer burden worldwide, advancements in oncology research, expanding access to healthcare, rising awareness and education, integration with multidisciplinary approaches. Major trends in the forecast period include rise in proton therapy integration, shift towards outpatient and freestanding centers, patient-centric treatment planning, growing clinical evidence and research, telemedicine and remote treatment planning.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/cyberknife-global-market-report
Segmentation & Regional Insights
The cyberknife market covered in this report is segmented –
1) By Type: Linear Accelerator-Based, Standalone Cyberknife
2) By Application: Tumor, Cancer, Vascular malformation, Other Applications
3) By End-User: Hospitals, Clinics, Ambulatory Surgical Center, Radiotherapy Centers, Other End Users
North America was the largest region in the cyberknife market in 2023. The regions covered in the cyberknife market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10562&type=smp
Major Driver Impacting Market Growth
The increasing incidence of cancer is expected to propel the growth of the cyberknife market going forward. Cancer is a severe disorder in which the body’s cells reproduce fast and uncontrollably, resulting in abnormal growth. Cyberknife is approved for treating a variety of cancers and is a non-invasive, non-surgical, pain-free treatment option where radiation therapy is indicated. The ongoing research and development activities to improve the cyberKnife system and expand its applications to other medical conditions are also expected to contribute to the growth of the market. For instance, in January 2022, according to ABC News Internet Ventures, a US-based newspaper company, in the year 2022, the anticipated number of newly diagnosed cancer cases is around 2 million, which represents a significant increase compared to the 1 million new cases reported in 2021. Approximately 5,250 new cases of cancer is diagnosed every day in the United States, totalling 1,918,030 Americans receiving a cancer diagnosis. Therefore, the increasing incidence of cancer is driving the growth of the cyberknife market.
Key Industry Players
Major companies operating in the cyberknife market report are Accuracy Inc., IBA Group, Mitsubishi Electric Corporation, Hitachi America Ltd., Sumitomo Heavy Industries Ltd., Nucletron B.V., General Electric Company, Varian Medical Systems Inc., RaySearch Laboratories AB, Brainlab AG, Nordion Inc., Modus Medical Devices Inc., Toshiba Medical Systems Corporation, ShenZhen Gene MDx Biotech Co. Ltd., ViewRay Inc., Mevion Medical Systems Inc., Isoray Inc., Optivus Proton Therapy Inc., Masep Medical Company, Best Medical International Inc., Huiheng Medical Inc., Cyber Medical Corporation, Siemens AG, Sun Nuclear Corporation, Koninklijke Philips N.V., CyberKnife Center of Miami, ALASKA CyberKnife Center, Elekta AB, RefleXion Medical Inc., ZAP Surgical Systems Inc., AccuBoost, Bionix Radiation Therapy LLC, C-RAD Co., Xcision Medical Systems LLC
The cyberknife market report table of contents includes:
- Executive Summary
- Cyberknife Market Characteristics
- Cyberknife Market Trends And Strategies
- Cyberknife Market – Macro Economic Scenario
- Global Cyberknife Market Size and Growth
- Cyberknife Market Segmentation
- Cyberknife Market Regional And Country Analysis
…………….
- Key Mergers And Acquisitions In The Cyberknife Market
- Cyberknife Market Future Outlook and Potential Analysis
- Appendix
List Of Tables:
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Cyberknife Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Cyberknife Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Cyberknife Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
…………
Table 73: Africa, Cyberknife Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 74: Accuracy Inc. Financial Performance
Table 75: IBA Group Financial Performance
Table 76: Mitsubishi Electric Corporation Financial Performance
Table 77: Hitachi America Ltd. Financial Performance
Table 78: Sumitomo Heavy Industries Ltd. Financial Performance
Explore the trending research reports from TBRC:
https://goodprnews.com/biodegradable-paper-and-plastic-packaging-market-statistics/
https://topprnews.com/blood-preparation-market-size/
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
